Fosamax treats one of the most common conditions associated with aging – loss of bone density, or osteoporosis/osteopenia. This medication is among the most widely prescribed in the world, but is also one of the most controversial.
Communications issued by the Food and Drug Administration, and subsequent lawsuits, have highlighted the incidence of a significant number of Fosamax patients suffering spontaneous femur fractures.
Femur fractures in Fosamax patients are most common in post-menopausal women and older men. Some of these fractures have been traced to improperly prescriptions for patients who did not need Fosamax. Most incidents occurred because patients trusted their physicians and the medication they were prescribing, only to discover that Fosamax was weakening, rather than strengthening, their bones.
What is Fosamax?
Fosamax is classified as a bisphosphonate and can be taken orally in pill or fluid form. Fosamax is manufactered by Merck and was released in 1995. In 2008 – amid numerous Fosamax lawsuits, concerns raised by medical researchers, and reports to the agency regarding side effects – the FDA required that pharmaceutical giant Merck & Co. Inc update their labeling. As a result, the medication’s warning label now includes the risk for femur fractures and other side effects.
Millions of Americans taking Fosamax have been unaware of the risks associated with this drug. If you or a loved one suffered a serious health problem as a result of this medication, you may be entitled to compensation for your medical costs and other expenses.
There may be legal time limits associated with your case, so please contact us as soon as possible for a free, no obligation consultation.